Idiopathic Pulmonary Fibrosis: How to Recognize and When to Refer

News
Slideshow

This compact yet detailed slide show offers primary care physicians a guide to essentials of IPF diagnosis and when to refer for pulmonary consult.

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Digital Asthma Program Improves Symptom Control in Adults: Daily Dose / image credit: ©New Africa/AdobeStock

Digital Asthma Program Improves Symptom Control in Adults: Daily Dose

Sydney Jennings
August 13th 2025
Article
Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
August 13th 2025
Podcast
Roche's Investigational Anti-IL-33/ST2 Antibody / image credit ©Sundry Photography/stock.adobe.com

Roche's Investigational Anti-IL-33/ST2 Antibody for COPD Misses Phase 3 Primary Endpoint

Grace Halsey
August 13th 2025
Article
NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
August 13th 2025
Podcast
Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD / image credit courtesy of Upstream Bio

Upstream Bio's TSLP Antagonist Verekitug Enters Global Phase 2 Trial for COPD

Grace Halsey
August 13th 2025
Article
Circulating Inflammatory Cells Persist in Severe Asthma Despite Biologic Therapy, Study Shows / image courtesy of Karolinska Institutet

Circulating Inflammatory Cells Persist in Severe Asthma Despite Biologic Therapy, Study Shows

Grace Halsey
August 13th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.